NCT05036421View on ClinicalTrials.gov

Effect of Glucuronosyltransferase (UGT) Genetic Variation on Pharmacokinetics of Empagliflozin

PHASE3CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

May 20, 2022

Study Completion Date

May 20, 2022

Conditions

PharmacogenomicPharmacokinetics

Interventions

DRUG

Empagliflozin 10 milligram

antihyperglycemic medication

Trial Locations (1)

Unknown

Faculty of Pharmacy, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER